Signaling pathways
-
F1812 Anti-TM4SF1 Antibody (Beth Israel Patent Anti-TM4SF1)Summary: Anti-TM4SF1 Antibody (Beth Israel Patent Anti-TM4SF1) -
F1813 Anti-TNFSF9/4-1BBL Antibody (Abbvie patent anti-TNFSF9)Summary: Anti-TNFSF9/4-1BBL Antibody (Abbvie patent anti-TNFSF9) -
F1814 Anti-TPBG Antibody (PF-06263507)Summary: Anti-TPBG Antibody (PF-06263507) -
F1815 Anti-TSHR Antibody (K1-70)Summary: Anti-TSHR Antibody (K1-70) -
F1816 Anti-VCAM1/CD106 Antibody (Hanwha patent anti-VCAM-1)Summary: Anti-VCAM1/CD106 Antibody (Hanwha patent anti-VCAM-1) -
F1817 Anti-VEGFR2/KDR/CD309 Antibody (AT001)Summary: Anti-VEGFR2/KDR/CD309 Antibody (AT001) -
F1818 Anti-L-selectin Antibody (Aselizumab)Summary: Anti-L-selectin Antibody (Aselizumab) -
F1819 Anti-Phosphorylcholine Antibody (ATH3G10)Summary: Anti-Phosphorylcholine Antibody (ATH3G10) -
F1820 Anti-PLAUR/uPAR/CD87 Antibody (ATN-658)Summary: Anti-PLAUR/uPAR/CD87 Antibody (ATN-658) -
F1821 Anti-SIRPa/CD172a Antibody (BI 765063)Summary: Anti-SIRPa/CD172a Antibody (BI 765063)